Microbiology Quiz: Complement System
20 questions · exam conditions
0:00
Complement SystemQuestion 1 of 20

A therapeutic monoclonal antibody is engineered to have a mutation in its Fc region that prevents it from binding C1q. When this antibody is used to target a bacterial pathogen, which complement-mediated effector function will be directly abolished?

Initiation of the classical pathway via immune complexes.
Stabilization of the alternative pathway C3 convertase.
Opsonization of the pathogen by C3b.
Recruitment of neutrophils by C5a.
← Back to quizzes

Microbiology Quiz

Microbiology Quiz: Complement System

Practice Complement System in Microbiology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Complement System, giving you a quick way to practice the rules, question types, and explanations that matter most for Microbiology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

A therapeutic monoclonal antibody is engineered to have a mutation in its Fc region that prevents it from binding C1q. When this antibody is used to target a bacterial pathogen, which complement-mediated effector function will be directly abolished?

  1. Initiation of the classical pathway via immune complexes. (correct answer)
  2. Stabilization of the alternative pathway C3 convertase.
  3. Opsonization of the pathogen by C3b.
  4. Recruitment of neutrophils by C5a.
Explanation: When you encounter questions about monoclonal antibodies and complement, focus on understanding which complement pathway is being affected and how that impacts downstream functions. The Fc region of antibodies contains the binding site for C1q, the first component of the classical complement pathway. When antibodies bind to pathogens and form immune complexes, C1q recognizes and binds to the Fc regions, initiating the classical pathway cascade. If the Fc region is mutated to prevent C1q binding, this critical first step cannot occur, directly abolishing classical pathway initiation via immune complexes (A). Let's examine why the other options remain unaffected: (B) is incorrect because alternative pathway C3 convertase stabilization occurs independently through factors like properdin and doesn't require antibody-C1q interaction. The alternative pathway uses different recognition mechanisms (like microbial surfaces) rather than immune complexes. (C) is wrong because C3b opsonization can still occur through the alternative pathway, which remains functional since it bypasses the C1q-dependent classical pathway initiation. (D) is incorrect because neutrophil recruitment by C5a can still happen via the alternative pathway, which can proceed to generate C5 convertase and subsequent C5a production without requiring classical pathway activation. Remember this key principle: when antibody function is impaired, focus on what's directly dependent on that specific antibody mechanism. The classical pathway uniquely requires antibody-antigen immune complexes for C1q recognition, making it the most vulnerable to Fc region mutations affecting C1q binding.

Question 2

A novel strain of Neisseria gonorrhoeae is found to secrete a protein that acts as a potent C3 convertase inhibitor, effective against both the classical and alternative pathway convertases. Which downstream event of the complement cascade would be the earliest to be completely blocked by this inhibitor?

  1. Binding of Mannose-Binding Lectin (MBL) to the bacterial surface.
  2. Generation of the inflammatory mediator C5a. (correct answer)
  3. Activation of C1 by IgM bound to bacterial antigen.
  4. Deposition of C4b on the pathogen surface.
Explanation: All complement pathways converge at the formation of C3 convertase, which cleaves C3. The next major step is the formation of C5 convertase (by adding C3b to C3 convertase) and the subsequent cleavage of C5 into C5a and C5b. If the C3 convertase is inhibited, C5 convertase cannot form, and C5a cannot be generated. Choices A, C, and D are all upstream events that occur before the action of C3 convertase and would not be blocked by its inhibitor.

Question 3

A patient with hereditary angioedema has a deficiency in C1 inhibitor (C1-INH). This leads to unregulated activity of C1, which in turn results in the excessive cleavage of which two complement proteins, leading to their depletion?

  1. C3 and C5
  2. Factor B and Properdin
  3. C4 and C2 (correct answer)
  4. C6 and C7
Explanation: C1 inhibitor (C1-INH) regulates the C1 complex (C1qrs). In its absence, activated C1s becomes overactive. The natural substrates for C1s are C4 and C2. Uncontrolled C1s activity leads to continuous cleavage and consumption of C4 and C2, causing their serum levels to be very low. While this can lead to some downstream C3 consumption, the primary and most marked depletion is of the direct substrates, C4 and C2. (The main symptoms of angioedema are due to C1-INH's effect on the kinin system, but the effect on complement is the depletion of C4 and C2).

Question 4

A researcher is studying chemotaxis of neutrophils toward a site of infection. The inflammatory exudate is found to contain high levels of C3a and C5a. While both are anaphylatoxins, blockade of the receptor for which molecule would most severely impair neutrophil recruitment?

  1. C3a, as it is generated in much higher quantities than C5a.
  2. C5a, as it is a significantly more potent chemotactic agent for neutrophils. (correct answer)
  3. C3a, because it is the primary activator of mast cells which release other chemoattractants.
  4. C5a, because it directly binds to and opsonizes bacteria for phagocytosis.
Explanation: While both C3a and C5a are inflammatory mediators (anaphylatoxins), C5a is the most potent complement-derived chemotactic factor for neutrophils, attracting them to the site of inflammation. Although more C3a is produced (A), the chemotactic potency of C5a is far greater, making it the critical driver of neutrophil recruitment. C5a also activates mast cells (C is not unique to C3a). C5a is not an opsonin; C3b is (D).

Question 5

A patient with a complete C2 deficiency is infected with an encapsulated bacterium. While the alternative and lectin pathways remain functional, which of the following complement-mediated activities will be most significantly impaired during the initial adaptive immune response to this pathogen?

  1. Formation of the C3bBb C3 convertase on the bacterial surface.
  2. Direct lysis of the bacterium via the membrane attack complex.
  3. Opsonization of the bacterium by spontaneously generated C3b.
  4. C1q-mediated clearance of antibody-antigen immune complexes. (correct answer)
Explanation: A C2 deficiency blocks the classical complement pathway. The classical pathway is initiated by C1q binding to antibody-antigen complexes. Therefore, the clearance of these immune complexes, a key function of the classical pathway, will be most significantly impaired. The alternative pathway (choice A and C) and lectin pathway are intact and can still lead to C3b deposition and subsequent MAC formation (partially addressing B), but the specific function tied to C1q and antibody is lost.

Question 6

A patient with paroxysmal nocturnal hemoglobinuria (PNH) has a deficiency in GPI-anchored proteins, including CD59 (protectin). This deficiency leads to complement-mediated intravascular hemolysis. Which specific step in the complement cascade is uncontrolled on the patient's erythrocytes?

  1. Spontaneous hydrolysis of C3, initiating the alternative pathway.
  2. Amplification of C3b deposition via the alternative pathway loop.
  3. Binding of C1q to the erythrocyte surface, initiating the classical pathway.
  4. Polymerization of C9 to complete the membrane attack complex pore. (correct answer)
Explanation: CD59 (protectin) is a key regulatory protein that prevents the final step of the membrane attack complex (MAC) formation. Specifically, it inhibits the binding and polymerization of C9 within the C5b-8 complex. In its absence, the MAC (C5b-9) can fully assemble on host cells like erythrocytes, leading to lysis. The other steps (A, B) are regulated by other proteins (like DAF and Factor H), and C1q binding (C) requires antibody, which is not the primary mechanism in PNH.

Question 7

A researcher identifies a bacterial species that evades the alternative complement pathway by promoting the binding of a host regulatory protein to C3b on its surface. This mechanism most likely involves mimicry of a host cell surface molecule that binds which regulator?

  1. C1 inhibitor (C1-INH)
  2. Decay-accelerating factor (DAF, CD55)
  3. Factor H (correct answer)
  4. Protectin (CD59)
Explanation: Host cells protect themselves from the alternative pathway by expressing surface molecules, such as sialic acid, that promote the binding of Factor H. Factor H then displaces Bb from C3b and acts as a cofactor for Factor I-mediated cleavage of C3b. A bacterium that mimics this host mechanism would promote Factor H binding to its own surface to shut down complement activation. C1-INH (A) regulates the classical pathway. DAF (B) and CD59 (D) are host-cell-bound proteins, not fluid-phase regulators recruited to the surface in the same way as Factor H.

Question 8

A novel strain of Neisseria gonorrhoeae is found to secrete a protein that acts as a potent C3 convertase inhibitor, effective against both the classical and alternative pathway convertases. Which downstream event of the complement cascade would be the earliest to be completely blocked by this inhibitor?

  1. Binding of Mannose-Binding Lectin (MBL) to the bacterial surface.
  2. Generation of the inflammatory mediator C5a. (correct answer)
  3. Activation of C1 by IgM bound to bacterial antigen.
  4. Deposition of C4b on the pathogen surface.
Explanation: All complement pathways converge at the formation of C3 convertase, which cleaves C3. The next major step is the formation of C5 convertase (by adding C3b to C3 convertase) and the subsequent cleavage of C5 into C5a and C5b. If the C3 convertase is inhibited, C5 convertase cannot form, and C5a cannot be generated. Choices A, C, and D are all upstream events that occur before the action of C3 convertase and would not be blocked by its inhibitor.

Question 9

A researcher is studying chemotaxis of neutrophils toward a site of infection. The inflammatory exudate is found to contain high levels of C3a and C5a. While both are anaphylatoxins, blockade of the receptor for which molecule would most severely impair neutrophil recruitment?

  1. C3a, as it is generated in much higher quantities than C5a.
  2. C5a, as it is a significantly more potent chemotactic agent for neutrophils. (correct answer)
  3. C3a, because it is the primary activator of mast cells which release other chemoattractants.
  4. C5a, because it directly binds to and opsonizes bacteria for phagocytosis.
Explanation: While both C3a and C5a are inflammatory mediators (anaphylatoxins), C5a is the most potent complement-derived chemotactic factor for neutrophils, attracting them to the site of inflammation. Although more C3a is produced (A), the chemotactic potency of C5a is far greater, making it the critical driver of neutrophil recruitment. C5a also activates mast cells (C is not unique to C3a). C5a is not an opsonin; C3b is (D).

Question 10

The membrane attack complex (MAC) is effective at lysing certain pathogens. Its lytic activity is significantly more potent against Escherichia coli than against Staphylococcus aureus primarily because of differences in which of the following structures?

  1. Presence of lipopolysaccharide (LPS) in the outer membrane.
  2. Thickness of the peptidoglycan cell wall. (correct answer)
  3. Expression of surface mannose residues.
  4. Formation of a protective polysaccharide capsule.
Explanation: E. coli is a Gram-negative bacterium with a thin peptidoglycan layer situated between two cell membranes. The MAC can readily insert into the outer membrane and lyse the cell. S. aureus is a Gram-positive bacterium with a very thick, external peptidoglycan wall that acts as a physical barrier, preventing the MAC from accessing and disrupting the underlying cell membrane. While LPS (A) can be a PAMP that activates complement, it doesn't prevent MAC function. Mannose (C) is relevant for lectin pathway activation, not MAC efficacy. Capsules (D) can inhibit complement activation in general, but the fundamental difference in MAC susceptibility between these two bacterial types is the cell wall structure.

Question 11

During the assembly of the Membrane Attack Complex (MAC), which component or complex is responsible for inserting into the lipid bilayer of the target cell, thereby providing an anchor for the subsequent assembly of the pore?

  1. The C5b-7 complex (correct answer)
  2. The C5b-6 complex
  3. The C8 protein
  4. A monomer of C9
Explanation: When you encounter questions about the Membrane Attack Complex (MAC), focus on the sequential assembly process and which components actually penetrate the target cell membrane. The MAC formation is a carefully orchestrated cascade where each step enables the next. The C5b-7 complex is the critical membrane-insertion unit that initiates pore formation. When C7 joins the C5b-6 complex, it undergoes a conformational change that exposes hydrophobic regions, allowing the entire C5b-7 complex to insert into the lipid bilayer. This insertion provides the essential membrane anchor that positions and stabilizes the growing MAC structure for subsequent component assembly. Let's examine why the other options miss the mark. Option B (C5b-6 complex) represents an earlier assembly intermediate that remains hydrophilic and cannot penetrate membranes—it requires C7 to gain membrane-insertion capability. Option C (C8 protein) binds to the already membrane-anchored C5b-7 complex and helps initiate the pore, but it's not the initial anchoring component. Option D (C9 monomer) polymerizes to form the final transmembrane pore, but this occurs only after the C5b-7 foundation is already established in the membrane. The correct answer is A—the C5b-7 complex serves as the membrane anchor that makes all subsequent MAC assembly possible. Study tip: Remember the MAC assembly sequence: C5b-6 forms in solution → C7 addition creates the membrane-inserting C5b-7 → C8 joins → C9 polymerizes. The transition from soluble to membrane-bound occurs specifically at the C5b-7 stage.

Question 12

The membrane attack complex (MAC) is effective at lysing certain pathogens. Its lytic activity is significantly more potent against Escherichia coli than against Staphylococcus aureus primarily because of differences in which of the following structures?

  1. Presence of lipopolysaccharide (LPS) in the outer membrane.
  2. Thickness of the peptidoglycan cell wall. (correct answer)
  3. Expression of surface mannose residues.
  4. Formation of a protective polysaccharide capsule.
Explanation: E. coli is a Gram-negative bacterium with a thin peptidoglycan layer situated between two cell membranes. The MAC can readily insert into the outer membrane and lyse the cell. S. aureus is a Gram-positive bacterium with a very thick, external peptidoglycan wall that acts as a physical barrier, preventing the MAC from accessing and disrupting the underlying cell membrane. While LPS (A) can be a PAMP that activates complement, it doesn't prevent MAC function. Mannose (C) is relevant for lectin pathway activation, not MAC efficacy. Capsules (D) can inhibit complement activation in general, but the fundamental difference in MAC susceptibility between these two bacterial types is the cell wall structure.

Question 13

During the assembly of the Membrane Attack Complex (MAC), which component or complex is responsible for inserting into the lipid bilayer of the target cell, thereby providing an anchor for the subsequent assembly of the pore?

  1. The C5b-7 complex (correct answer)
  2. The C5b-6 complex
  3. The C8 protein
  4. A monomer of C9
Explanation: When you encounter questions about the Membrane Attack Complex (MAC), focus on the sequential assembly process and which components actually penetrate the target cell membrane. The MAC formation is a carefully orchestrated cascade where each step enables the next. The C5b-7 complex is the critical membrane-insertion unit that initiates pore formation. When C7 joins the C5b-6 complex, it undergoes a conformational change that exposes hydrophobic regions, allowing the entire C5b-7 complex to insert into the lipid bilayer. This insertion provides the essential membrane anchor that positions and stabilizes the growing MAC structure for subsequent component assembly. Let's examine why the other options miss the mark. Option B (C5b-6 complex) represents an earlier assembly intermediate that remains hydrophilic and cannot penetrate membranes—it requires C7 to gain membrane-insertion capability. Option C (C8 protein) binds to the already membrane-anchored C5b-7 complex and helps initiate the pore, but it's not the initial anchoring component. Option D (C9 monomer) polymerizes to form the final transmembrane pore, but this occurs only after the C5b-7 foundation is already established in the membrane. The correct answer is A—the C5b-7 complex serves as the membrane anchor that makes all subsequent MAC assembly possible. Study tip: Remember the MAC assembly sequence: C5b-6 forms in solution → C7 addition creates the membrane-inserting C5b-7 → C8 joins → C9 polymerizes. The transition from soluble to membrane-bound occurs specifically at the C5b-7 stage.

Question 14

A patient with hereditary angioedema has a deficiency in C1 inhibitor (C1-INH). This leads to unregulated activity of C1, which in turn results in the excessive cleavage of which two complement proteins, leading to their depletion?

  1. C3 and C5
  2. Factor B and Properdin
  3. C4 and C2 (correct answer)
  4. C6 and C7
Explanation: C1 inhibitor (C1-INH) regulates the C1 complex (C1qrs). In its absence, activated C1s becomes overactive. The natural substrates for C1s are C4 and C2. Uncontrolled C1s activity leads to continuous cleavage and consumption of C4 and C2, causing their serum levels to be very low. While this can lead to some downstream C3 consumption, the primary and most marked depletion is of the direct substrates, C4 and C2. (The main symptoms of angioedema are due to C1-INH's effect on the kinin system, but the effect on complement is the depletion of C4 and C2).

Question 15

A therapeutic monoclonal antibody is engineered to have a mutation in its Fc region that prevents it from binding C1q. When this antibody is used to target a bacterial pathogen, which complement-mediated effector function will be directly abolished?

  1. Initiation of the classical pathway via immune complexes. (correct answer)
  2. Stabilization of the alternative pathway C3 convertase.
  3. Opsonization of the pathogen by C3b.
  4. Recruitment of neutrophils by C5a.
Explanation: When you encounter questions about monoclonal antibodies and complement, focus on understanding which complement pathway is being affected and how that impacts downstream functions. The Fc region of antibodies contains the binding site for C1q, the first component of the classical complement pathway. When antibodies bind to pathogens and form immune complexes, C1q recognizes and binds to the Fc regions, initiating the classical pathway cascade. If the Fc region is mutated to prevent C1q binding, this critical first step cannot occur, directly abolishing classical pathway initiation via immune complexes (A). Let's examine why the other options remain unaffected: (B) is incorrect because alternative pathway C3 convertase stabilization occurs independently through factors like properdin and doesn't require antibody-C1q interaction. The alternative pathway uses different recognition mechanisms (like microbial surfaces) rather than immune complexes. (C) is wrong because C3b opsonization can still occur through the alternative pathway, which remains functional since it bypasses the C1q-dependent classical pathway initiation. (D) is incorrect because neutrophil recruitment by C5a can still happen via the alternative pathway, which can proceed to generate C5 convertase and subsequent C5a production without requiring classical pathway activation. Remember this key principle: when antibody function is impaired, focus on what's directly dependent on that specific antibody mechanism. The classical pathway uniquely requires antibody-antigen immune complexes for C1q recognition, making it the most vulnerable to Fc region mutations affecting C1q binding.

Question 16

A researcher identifies a bacterial species that evades the alternative complement pathway by promoting the binding of a host regulatory protein to C3b on its surface. This mechanism most likely involves mimicry of a host cell surface molecule that binds which regulator?

  1. C1 inhibitor (C1-INH)
  2. Decay-accelerating factor (DAF, CD55)
  3. Factor H (correct answer)
  4. Protectin (CD59)
Explanation: Host cells protect themselves from the alternative pathway by expressing surface molecules, such as sialic acid, that promote the binding of Factor H. Factor H then displaces Bb from C3b and acts as a cofactor for Factor I-mediated cleavage of C3b. A bacterium that mimics this host mechanism would promote Factor H binding to its own surface to shut down complement activation. C1-INH (A) regulates the classical pathway. DAF (B) and CD59 (D) are host-cell-bound proteins, not fluid-phase regulators recruited to the surface in the same way as Factor H.

Question 17

A patient is found to have a complete deficiency of Mannose-Binding Lectin (MBL). This individual would likely have the most difficulty controlling infections during which specific period?

  1. The first 4 hours after initial exposure to any pathogen.
  2. From 1 to 4 days post-infection, before an adaptive response is mounted. (correct answer)
  3. During the memory response to a previously encountered pathogen.
  4. During chronic viral infections where cell-mediated immunity is paramount.
Explanation: The immune response has several phases. The immediate innate response (0-4 hours) relies on pre-formed effectors. The early induced innate response (4 hours to 4 days) is critical for controlling infection before adaptive immunity is engaged. The MBL/lectin pathway is a key component of this early induced phase, recognizing carbohydrates on pathogens without needing antibodies. A deficiency would create a window of vulnerability during this period. The alternative pathway contributes immediately (A), but the lectin pathway is a major induced component. The memory response (C) is dominated by antibodies activating the classical pathway. Chronic viral infections (D) rely more on T-cells and NK cells.

Question 18

A patient with paroxysmal nocturnal hemoglobinuria (PNH) has a deficiency in GPI-anchored proteins, including CD59 (protectin). This deficiency leads to complement-mediated intravascular hemolysis. Which specific step in the complement cascade is uncontrolled on the patient's erythrocytes?

  1. Spontaneous hydrolysis of C3, initiating the alternative pathway.
  2. Amplification of C3b deposition via the alternative pathway loop.
  3. Binding of C1q to the erythrocyte surface, initiating the classical pathway.
  4. Polymerization of C9 to complete the membrane attack complex pore. (correct answer)
Explanation: CD59 (protectin) is a key regulatory protein that prevents the final step of the membrane attack complex (MAC) formation. Specifically, it inhibits the binding and polymerization of C9 within the C5b-8 complex. In its absence, the MAC (C5b-9) can fully assemble on host cells like erythrocytes, leading to lysis. The other steps (A, B) are regulated by other proteins (like DAF and Factor H), and C1q binding (C) requires antibody, which is not the primary mechanism in PNH.

Question 19

A patient with systemic lupus erythematosus (SLE) shows laboratory results of low serum C3 and low serum C4. This pattern is most indicative of the chronic activation of which complement pathway?

  1. The alternative pathway, due to constant C3 tick-over.
  2. The classical pathway, due to circulating immune complexes. (correct answer)
  3. The lectin pathway, due to recognition of altered self-glycans.
  4. All three pathways equally, due to systemic inflammation.
Explanation: SLE is characterized by the production of autoantibodies, which form immune complexes. These immune complexes are potent activators of the classical pathway, starting with C1q binding. Activation of the classical pathway consumes both C4 and C2 (forming C4b2a) and subsequently C3. Therefore, low levels of both C4 and C3 strongly suggest classical pathway activation. The alternative pathway (A) would primarily consume C3, leaving C4 levels relatively normal. The lectin pathway (C) also consumes C4 and C3, but immune complex-mediated activation is the hallmark of SLE.

Question 20

A patient with a complete C2 deficiency is infected with an encapsulated bacterium. While the alternative and lectin pathways remain functional, which of the following complement-mediated activities will be most significantly impaired during the initial adaptive immune response to this pathogen?

  1. Formation of the C3bBb C3 convertase on the bacterial surface.
  2. Direct lysis of the bacterium via the membrane attack complex.
  3. Opsonization of the bacterium by spontaneously generated C3b.
  4. C1q-mediated clearance of antibody-antigen immune complexes. (correct answer)
Explanation: A C2 deficiency blocks the classical complement pathway. The classical pathway is initiated by C1q binding to antibody-antigen complexes. Therefore, the clearance of these immune complexes, a key function of the classical pathway, will be most significantly impaired. The alternative pathway (choice A and C) and lectin pathway are intact and can still lead to C3b deposition and subsequent MAC formation (partially addressing B), but the specific function tied to C1q and antibody is lost.